Adama uses its own technical, the world's first Saflufenacil products

 Adama recently announced that Sierra®, the first generic herbicide based on its original product of Saflufenacil, has been successfully registered in Australia.

Sierra®, developed with Adama's unique formulation technology platform, provides farmers with an important resistance management tool that is effective against annual and broadleaf weeds and meets the needs of a wide range of crops and off-farm plant protection, maximizing efficiency while minimizing the loss of valuable soil water. The superior and consistent efficacy of Sierra® compared to existing solutions has been demonstrated in hundreds of trials under different conditions.

"Saflufenacil is one of the company's strategic technical, and this is the first product registration of Saflufenacil that we have obtained in the world, which is an important milestone." Walter Costa, Vice President of Marketing and Product Strategy at Adama, said: "The registration of this important technical in Australia demonstrates our commitment to focus on delivering innovative solutions to meet the needs of farmers and the agile nature of Adama's strategy. We are excited to bring to market this patented high performance product, which is the culmination of Adama's comprehensive crop protection solutions for grain and bean growers around the world."

Adama expects the product to be registered in Brazil, Canada, Argentina, South Africa and other countries over the next few years.

What is Adama's "core jump" strategy?

To enhance the commercial potential and sustainability of Adama's product portfolio, the company has selected 24 advanced agents with expiring patents in the industry as the cornerstone of Adama's innovative pipeline, which will be optimized for efficacy and formulated into more efficient, longer lasting and easier to use formulations supported by Adama's unique formulation technology platform.